In vitro Evaluation and Molecular Docking Analysis of Potential Anticancer Compounds from Syzygium alternifolium
M. Lakshmi Madhuri, R. Raja Reddy
International Research Journal of Pure and Applied Chemistry · pp. 1–8 · Published 23 Nov 2022
10.9734/irjpac/2022/v23i6791Abstract
Around the world, Syzygium alternifolium is widely distributed in tropical and subtropical areas. This plant has traditionally been used to treat a variety of illnesses, including cancer. The current research compared the standard drug doxorubicin to the anticancer activity of methanolic extract of Syzygium alternifolium bark on human hepatocyte carcinoma (HepG2) cell line. Through DNA intercalation, inhibition of topoisomerase-II-mediated DNA repair, free radical production and consequent damage to cellular membranes, DNA, and proteins, doxorubicin exerts its anticancer activity in cancerous cells. Research on cytotoxicity have shown that Syzygium alternifolium phytoconstituents can selectively target cancer cells (IC50 = 185.585 µg/ml), while having little to no cytotoxic effects on normal cells Using Mcule docking software, molecular docking studies were performed against the human Topoisomerase-2 and CDK-2 proteins (Protein Data Bank-ID: 1ZXM and 1DI8, respectively). Seven compounds from the bioactives isolated are considered as safe inhibitors, according to in silico studies. In order to better understand the probable mechanisms of action and create more efficient and cost-effective therapies, molecular docking experiments were carried out employing phytoconstituents. This study demonstrates a significant consistency of anticancer therapeutic drug potentials of Syzygium alternifolium by in vitro and in silico approaches, leading the way for a better understanding of how integrating molecular docking and in vitro studies can improve the identification of cancer drugs.
References (16)
- 1 DNA topoisomerase II and its growing repertoire of biological functions [DOI]
- 2 Kaempferol: A Key Emphasis to Its Anticancer Potential [DOI]
- 3 Anticancer potential of quercetin: A comprehensive review [DOI]
- 4 Apigenin in cancer therapy: anti-cancer effects and mechanisms of action [DOI]
- 5 Epidemiology of Opisthorchis viverrini [DOI]
- 6 Experimental models of hepatocellular carcinoma [DOI]
- 7 Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C [DOI]
- 8 Desirable cell death during anticancer chemotherapy [DOI]
- 9 Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? [DOI]
- 10 Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma [DOI]
- 11 In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line [DOI]
- 12 Molecular Docking Simulation Studies of Curcumin and Its Derivatives as Cyclin-Dependent Kinase 2 Inhibitors [DOI]
- 13 Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1 [DOI]
- 14 Isolation, in vitro antidiabetic, antioxidant activity and molecular docking studies of pentacyclic triterpenoids from Syzygium alternifolium (wt.) Walp bark
- 15 Screening for cytotoxic activity of Habenaria longicorniculata J graham tubers- an in-vitro study [DOI]
- 16 Isolation and characterization of triterpenoids from bark of Syzygium alternifolium (Wight) Walp
Cited by 2
Luqman Alwi, Irwan Budiono, M. Azam · TRENDS IN THE SCIENCES · 2026
A. Khalaf, OA Omar · International Journal of Drug Delivery Technology · 2023
Related research
- Glycosylated Antibiotics: New Promising Bacterial Efflux Pumps Inhibitors — shares topic coverage
- Integrating In-silico and In-vitro Approaches to Screen the Antidiabetic Drug from Trigonella foenum graecum Linn. — shares topic coverage
- Structural Mapping of Inhibitors Binding Sites on P-glycoprotein: Mechanism of Inhibition of P-Glycoprotein by Herbal Isoflavones — shares topic coverage
- Azamacrocycle Complexes: Synthesis and Xanthine Oxidase and Antioxidant Activity — shares topic coverage
- Evaluation of Selected Natural Compounds for Cancer Stem Cells Targeted Anti-cancer Activity: A Molecular Docking Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
29
Page views
0
PDF downloads
4
Outbound clicks
2
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.